• Submission

Journal of Pharmaceutical Research International

  • About
    • About the Journal
    • Submissions & Author Guideline
    • Articles in Press
    • Editorial Policy
    • Editorial Board Members
    • Reviewers
    • Propose a Special Issue
    • Reprints
    • Subscription
    • Membership
    • Publication Ethics and Malpractice Statement
    • Digital Archiving Policy
    • Contact
  • Archives
  • Indexing
  • Publication Charge
  • Books
  • Testimonials
Advanced Search
  1. Home
  2. Archives
  3. 2020 - Volume 32 [Issue 21]
  4. Original Research Article

Submit Manuscript


Subscription



  • Home Page
  • Author Guidelines
  • Editorial Board Member
  • Editorial Policy
  • Propose a Special Issue
  • Membership

Detection of H. pylori IgG by Using ELISA

  • Malabika Mahato

Journal of Pharmaceutical Research International, Page 102-106
DOI: 10.9734/jpri/2020/v32i2130759
Published: 7 September 2020

  • View Article
  • Download
  • Cite
  • References
  • Statistics
  • Share

Abstract


Background: Helicobacter pylori is a Gram-negative, winding, microaerophilic human pathogen and have indicated solid relationship with different gastroduodenal illnesses. Its contagion is one of the most widely recognized interminable diseases in humans since the isolation of the pathogen (1–3).


Aim and Objectives: This examination was directed to discover the affectability and particularity of ELISA in distinguishing H. pylori.


Materials and Methods: The investigation was completed in the Department of Pathology, Sri Balaji Medical College and Hospital, Chennai for a period from November 2016 to October 2018. The research was planned as Prospective study. The study recruited two population of respondents comprising of 50 symptomatic clinicians and 50 infection populations of either sex, over 18 years of age. Patients with signs identified with the upper gastrointestinal tract prompted by endoscopic examination and identified as having gastritis, peptic ulcer (PU) and those patients were recalled for this investigation. Patients who took treatment of pylori destruction and use of antimicrobial agents, neutron siphon agonists, bismuth containing mixtures during the month prior to endometrial biopsy were removed from the inquiry. All essential history, clinical breakthroughs and research facility records of each subject were methodically documented in Microsoft windows sensitive Excel sheet for the consequent examination. Arterial blood samples were collected for the Enzyme Linked Immunosorbent Assay (ELISA) test. For this, 50 people of either sex matured over 18 years of age were considered.


Results: It was observed that, the normal age of the patient was 40 to 60 years, 56% of them were male and 44% female. In this examination, serology tests to recognize IgG counter acting agent demonstrated the affectability of (60%). By and large, low precision and affectability of IgG serological tests is because of the failure to separate among present and past disease. Conclusion: These examinations show that H. pylori contamination is a typical issue among individuals in tamilnadu, India. The titer of IgG antibodies to H. pylori in serum can be utilized as non-intrusive tests for the presence of gastritis.


Keywords:
  • Helicobacter pylori
  • IgG
  • seroprevalence
  • ELISA.
  • Full Article - PDF
  • Review History

How to Cite

Mahato, M. (2020). Detection of H. pylori IgG by Using ELISA. Journal of Pharmaceutical Research International, 32(21), 102-106. https://doi.org/10.9734/jpri/2020/v32i2130759
  • ACM
  • ACS
  • APA
  • ABNT
  • Chicago
  • Harvard
  • IEEE
  • MLA
  • Turabian
  • Vancouver

References

Dutta D, Clevers H. Organoid culture systems to study host–pathogen interactions. Current Opinion in Immunology; 2017.

Kumari PR. A study of Helicobacter pylori in gastroduodenal diseases. Int J Curr Microbiol Appl Sci; 2014.

Ogihara A, Kikuchi S, Hasegawa A, Kurosawa M, Miki K, Kaneko E, et al. Relationship between Helicobacter pylori infection and smoking and drinking habits. J Gastroenterol Hepatol; 2000.

Marshall B, Azad M. Q&A: Barry Marshall. A bold experiment. Nature; 2014.

D’Elios MM. [Helicobacter pylori, the story so far]. Med Secoli; 2007.

Sipponen P, Price AB. The Sydney System for classification of gastritis 20 years ago. Journal of Gastroenterology and Hepatology (Australia); 2011.

Kusters JG, Van Vliet AHM, Kuipers EJ. Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev; 2006.

Cover TL, Blaser MJ. Helicobacter pylori in Health and Disease. Gastroenterology; 2009.

Wroblewski LE, Peek RM, Wilson KT. Helicobacter pylori and gastric cancer: Factors that modulate disease risk. Clinical Microbiology Reviews; 2010.

Ahmed N, Tenguria S, Nandanwar N. Helicobacter pylori--a seasoned pathogen by any other name. Gut Pathog; 2009.

Exner MM, Doig P, Trust TJ, Hancock REW. Isolation and characterization of a family of porin proteins from Helicobacter pylori. Infect Immun; 1995.

Carlini CR, Ligabue-Braun R. Ureases as multifunctional toxic proteins: A review. Toxicon; 2016.

Vale FF, Vítor JMB. Transmission pathway of Helicobacter pylori: Does food play a role in rural and urban areas? International Journal of Food Microbiology; 2010.

Gralnek I, Dumonceau J-M, Kuipers E, Lanas A, Sanders D, Kurien M, et al. Diagnosis and management of nonvariceal upper gastrointestinal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy; 2015.

Gralnek IM, Dumonceau JM, Kuipers EJ, Lanas A, Sanders DS, Kurien M, et al. Diagnosis and management of nonvariceal upper gastrointestinal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy; 2015.

Fock KM, Katelaris P, Sugano K, Ang TL, Hunt R, Talley NJ, et al. Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection. J Gastroenterol Hepatol; 2009.

Patel SK, Pratap CB, Jain AK, Gulati AK, Nath G. Diagnosis of Helicobacter pylori: What should be the gold standard? World J Gastroenterol. 2014;20(36): 12847–59.

Ochola LB, Vounatsou P, Smith T, Mabaso MLH, Newton CRJC. The reliability of diagnostic techniques in the diagnosis and management of malaria in the absence of a gold standard. Lancet Infect Dis; 2006.
  • Abstract View: 229 times
    PDF Download: 200 times

Download Statistics

Downloads

Download data is not yet available.
  • Linkedin
  • Twitter
  • Facebook
  • Google Plus
  • Telegram
Make a Submission / Login
Information
  • For Readers
  • For Authors
  • For Librarians
Current Issue
  • Atom logo
  • RSS2 logo
  • RSS1 logo


© Copyright 2010-Till Date, Journal of Pharmaceutical Research International. All rights reserved.